Notably, the tumor cell and peripheral blood mononuclear cells (PBMCs) coculture assay demonstrated that decreased STAMBPL1 expression could lead to enhanced CD8+ T cell–mediated cytotoxicity (Figure S27C,D, Supporting Information). The gene discussed is CD8A; the disease is neoplasm.